Cyclin B2 has been shown to stimulate the proliferation of triple negative breast cancer cells [47] and to alter mitotic spindle checkpoint control leading to the genomic instability seen in cancer [48]. This evidence concerns the gene CCNB2 and triple-negative breast carcinoma.